Patents by Inventor Andreas Lutterotti

Andreas Lutterotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING A FATIGUE VALUE OF A PERSON
    Publication number: 20260047787
    Abstract: The invention relates to a method, particularly a computer-implemented method for determining a fatigue value of a person, the method comprising the steps of: i) displaying of: a) a first group (1) of symbols and a second group (2) of symbols, b) a selection rule (3) associating each of the symbols of the first group (1) of symbols to one symbol of the second group (2) of symbols, ii) highlighting one symbol (11) of the first group (1) of symbols, iii) receiving a user input from the person selecting one symbol (12) of the second group (2) of symbols, iv) determining a truth value based on the selected symbol (12) of the second group (2) of symbols, wherein the truth value assumes a true value if the selected symbol (12) is selected in accordance with the selection rule (3) and wherein the truth value takes on a false value if not, wherein the highlighted symbol (11) of the first group (1) of symbols is highlighted for a predetermined time based on a statistical response time of the person, and wherein
    Type: Application
    Filed: August 11, 2023
    Publication date: February 19, 2026
    Applicants: UNIVERSITÄT ZÜRICH, ETH ZÜRICH
    Inventors: Andreas LUTTEROTTI, Pietro OLDRATI, Rok AMON, Marc HILTY, Liliana BARRIOS
  • METHOD FOR STRATIFICATION AND TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20240329043
    Abstract: The disclosure relates to the field of multiple sclerosis (MS) stratification by analyzing the body fluid of an MS patient. The invention also relates to the field of antigen specific immunotherapies, such as the induction of tolerance.
    Type: Application
    Filed: July 14, 2022
    Publication date: October 3, 2024
    Applicant: Universität Zurich
    Inventors: Mireia SOSPEDRA RAMOS, Roland MARTIN, Raquel PLANAS, Andreas LUTTEROTTI
  • Use of modified cells for the treatment of multiple sclerosis
    Patent number: 9260692
    Abstract: The present invention describes blood cells chemically coupled with immunodominant myelin peptides and their use in the treatment of Multiple Sclerosis.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: February 16, 2016
    Assignee: UNIVERSITAT ZURICH
    Inventors: Roland Martin, Andreas Lutterotti
  • USE OF MODIFIED CELLS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20140212445
    Abstract: The present invention describes blood cells chemically coupled with immunodominant myelin peptides and their use in the treatment of Multiple Sclerosis.
    Type: Application
    Filed: March 18, 2014
    Publication date: July 31, 2014
    Applicant: UNIVERSITAT ZURICH
    Inventors: Roland MARTIN, Andreas LUTTEROTTI
  • Use of modified cells for the treatment of multiple sclerosis
    Patent number: 8673293
    Abstract: The present invention describes blood cells chemically coupled with immunodominant myelin peptides and their use in the treatment of Multiple Sclerosis.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: March 18, 2014
    Assignee: Universitat Zurich
    Inventors: Roland Martin, Andreas Lutterotti, Stephen Miller
  • USE OF MODIFIED CELLS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20110033426
    Abstract: The present invention describes blood cells chemically coupled with immunodominant myelin peptides and their use in the treatment of Multiple Sclerosis.
    Type: Application
    Filed: October 31, 2008
    Publication date: February 10, 2011
    Applicant: UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF
    Inventors: Roland Martin, Andreas Lutterotti, Stephen Miller